BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2024 10:58:28 AM | Browse: 149 | Download: 858
 |
Received |
|
2024-01-15 12:38 |
|
Peer-Review Started |
|
2024-01-15 12:38 |
|
First Decision by Editorial Office Director |
|
2024-03-05 20:46 |
|
Return for Revision |
|
2024-03-05 20:46 |
|
Revised |
|
2024-03-19 10:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-25 02:55 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-25 03:34 |
|
Articles in Press |
|
2024-04-25 03:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-08 05:43 |
|
Publish the Manuscript Online |
|
2024-05-11 10:58 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Ya Yin, Tian-Yuan Yang, Bing-Qing Yang, Chen-Xue Hou, Jun-Nan Li, Yue Li and Qi Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82170591 |
| Natural Science Foundation of Beijing |
7222097 |
|
| Corresponding Author |
Qi Wang, MD, PhD, Associate Professor, Associate Research Scientist, Chief Physician, Doctor, Doctor, Teacher, Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. wangqidl04@ccmu.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; High-risk metabolic dysfunction-associated steatohepatitis; Non-invasive models; Liver biopsy; Diagnostic value |
| Core Tip |
Patients with high-risk metabolic dysfunction-associated steatohepatitis (MASH) are more likely to develop cirrhosis or hepatocellular carcinoma. Early diagnosis, particularly without a liver biopsy, presents significant challenges. Exploring non-invasive models may increase detection efficiency. Although metabolic dysfunction-associated steatotic liver disease originates from non-alcoholic fatty liver disease, patient cohorts do not entirely overlap. Our study validated the concordance between these two distinct populations. To determine the effective replacement of liver biopsy with non-invasive models for diagnosing high-risk MASH, we utilized existing data to select seven diagnostic methods and assessed their diagnostic value for high-risk MASH. |
| Publish Date |
2024-05-11 10:58 |
| Citation |
Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2024; 30(18): 2440-2453 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i18/2440.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i18.2440 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
